Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.95USD
18 Jan 2019
Change (% chg)

$-0.06 (-1.99%)
Prev Close
$3.01
Open
$3.03
Day's High
$3.03
Day's Low
$2.92
Volume
9,977
Avg. Vol
20,577
52-wk High
$8.55
52-wk Low
$1.96

Chart for

About

Cidara Therapeutics Inc., is a clinical-stage biotechnology company focused on developing new anti-infectives. The Company’s lead product candidate is rezafungin acetate, which is a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and... (more)

Overall

Beta: --
Market Cap(Mil.): $123.10
Shares Outstanding(Mil.): 16.86
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -3.55 -- --
ROI: -72.93 8.99 14.48
ROE: -77.58 10.13 15.99

Earnings vs. Estimates